These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 30613270)

  • 21. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
    Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
    Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
    [No Abstract]   [Full Text] [Related]  

  • 22. Pretargeted immunoPET of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody in mice with PC3 xenografts.
    van Rij CM; Frielink C; Goldenberg DM; Sharkey RM; Franssen GM; Lütje S; McBride WJ; Oyen WJ; Boerman OC
    Mol Imaging Biol; 2015 Feb; 17(1):94-101. PubMed ID: 25060065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Preliminary Study of PSMA Fluorescent Probe for Targeted Fluorescence Imaging of Prostate Cancer.
    Zhou H; Liu Y; Zhang X; Chen K; Li Y; Xu X; Xu B
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566085
    [No Abstract]   [Full Text] [Related]  

  • 24. Noninvasive Evaluation of Multidrug Resistance via Imaging of ABCG2/BCRP Multidrug Transporter in Lung Cancer Xenograft Models.
    Li C; Yang Q; Chen Z; Qiu Y; Du Y; Wang R; He Q; Yang J; Zhen H; Kang L
    Mol Pharm; 2022 Oct; 19(10):3521-3529. PubMed ID: 35427142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Gastrin-Releasing Peptide Receptor Targeted Near-Infrared Fluorescence Dye for Image-Guided Surgery of Prostate Cancer.
    Pagoto A; Garello F; Marini GM; Tripepi M; Arena F; Bardini P; Stefania R; Lanzardo S; Valbusa G; Porpiglia F; Manfredi M; Aime S; Terreno E
    Mol Imaging Biol; 2020 Feb; 22(1):85-93. PubMed ID: 31025163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer.
    Foss CA; Fox JJ; Feldmann G; Maitra A; Iacobuzio-Donohue C; Kern SE; Hruban R; Pomper MG
    Mol Imaging; 2007; 6(2):131-9. PubMed ID: 17445507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.
    Holland JP; Divilov V; Bander NH; Smith-Jones PM; Larson SM; Lewis JS
    J Nucl Med; 2010 Aug; 51(8):1293-300. PubMed ID: 20660376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors.
    Bäck TA; Jennbacken K; Hagberg Thulin M; Lindegren S; Jensen H; Olafsen T; Yazaki PJ; Palm S; Albertsson P; Damber JE; Wu AM; Welén K
    EJNMMI Res; 2020 Feb; 10(1):10. PubMed ID: 32048062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors.
    Lütje S; Heskamp S; Franssen GM; Frielink C; Kip A; Hekman M; Fracasso G; Colombatti M; Herrmann K; Boerman OC; Gotthardt M; Rijpkema M
    Theranostics; 2019; 9(10):2924-2938. PubMed ID: 31244933
    [No Abstract]   [Full Text] [Related]  

  • 30. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
    Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
    J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PSMA-11-Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer.
    Baranski AC; Schäfer M; Bauder-Wüst U; Roscher M; Schmidt J; Stenau E; Simpfendörfer T; Teber D; Maier-Hein L; Hadaschik B; Haberkorn U; Eder M; Kopka K
    J Nucl Med; 2018 Apr; 59(4):639-645. PubMed ID: 29191856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering A11 Minibody-Conjugated, Polypeptide-Based Gold Nanoshells for Prostate Stem Cell Antigen (PSCA)-Targeted Photothermal Therapy.
    Mayle KM; Dern KR; Wong VK; Chen KY; Sung S; Ding K; Rodriguez AR; Knowles S; Taylor Z; Zhou ZH; Grundfest WS; Wu AM; Deming TJ; Kamei DT
    SLAS Technol; 2017 Feb; 22(1):26-35. PubMed ID: 27659802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic efficacy of I131-PSCA-mAb in orthotopic mouse models of prostate cancer.
    Yu S; Feng F; Wang K; Men C; Lin C; Liu Q; Yang D; Gao Z
    Eur J Med Res; 2013 Dec; 18(1):56. PubMed ID: 24330823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomographic imaging of iodine 124 anti-prostate stem cell antigen-engineered antibody fragments in LAPC-9 tumor-bearing severe combined immunodeficiency mice.
    Fonge H; Leyton JV
    Mol Imaging; 2013 May; 12(3):191-202. PubMed ID: 23490445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives.
    Viola-Villegas NT; Sevak KK; Carlin SD; Doran MG; Evans HW; Bartlett DW; Wu AM; Lewis JS
    Mol Pharm; 2014 Nov; 11(11):3965-73. PubMed ID: 24779727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Utility of [
    Beinat C; Haywood T; Chen YS; Patel CB; Alam IS; Murty S; Gambhir SS
    Mol Imaging Biol; 2018 Dec; 20(6):1015-1024. PubMed ID: 29736561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody ⁸⁹Zr-RG7116.
    Terwisscha van Scheltinga AG; Lub-de Hooge MN; Abiraj K; Schröder CP; Pot L; Bossenmaier B; Thomas M; Hölzlwimmer G; Friess T; Kosterink JG; de Vries EG
    MAbs; 2014; 6(4):1051-8. PubMed ID: 24870719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice.
    Stillebroer AB; Franssen GM; Mulders PF; Oyen WJ; van Dongen GA; Laverman P; Oosterwijk E; Boerman OC
    Cancer Biother Radiopharm; 2013 Sep; 28(7):510-5. PubMed ID: 23697926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.
    Leyton JV; Olafsen T; Sherman MA; Bauer KB; Aghajanian P; Reiter RE; Wu AM
    Protein Eng Des Sel; 2009 Mar; 22(3):209-16. PubMed ID: 18957406
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.